Featured Research

from universities, journals, and other organizations

Possible New Cure For Psoriasis

Date:
August 17, 2004
Source:
University Of Bonn
Summary:
Cell biologists of the University of Bonn, in cooperation with the University of Leeds (U.K.) and industry may have discovered a new effective therapy for psoriasis: a specific group of what are known as metalloproteinase inhibitors can normalise the increased tendency of epidermis cells (keratinocytes) to divide, which is the cause of this unpleasant lepidosis.

Christina Siemes and professor Herzog show a model of the epidermis.
Credit: Photo courtesy of University Of Bonn

Cell biologists of the University of Bonn, in cooperation with the University of Leeds (U.K.) and industry may have discovered a new effective therapy for psoriasis: a specific group of what are known as metalloproteinase inhibitors can normalise the increased tendency of epidermis cells (keratinocytes) to divide, which is the cause of this unpleasant lepidosis. The researchers were not able to detect any toxic side-effects, at least not in cell cultures. Their findings are now being published in the Journal of Investigative Dermatology (Vol. 123, No. 3).

About two million Germans suffer from psoriasis (from the Greek psora meaning 'itching, scratching'). In this incurable disease the regeneration of the epidermis is speeded up enormously: whereas it normally renews itself in just under four weeks, this period is cut to four to seven days in psoriasis patients. The reason is the greatly increased rate of cell division of the keratinocytes. They form a layer which separates the epidermis from the dermis, which lies beneath it. The ageing cells pass from this germinal layer to the surface until they finally scale off.

The disease progresses in waves. Its typical features are clearly defined red areas which are covered with silvery white scales. In the Middle Ages they were thought to be the symptoms of leprosy; a large number of the 'lepers' who were persecuted and even burnt were probably suffering from psoriasis, which is not contagious. What is worse than the changes to the skin itself is the stigma attached to the disease: 'During one of the periods when the disease is more intense many patients think that it is unreasonable to expect people to put up with their presence,' the Bonn cytobiologist Professor Volker Herzog explains. 'Some patients withdraw completely; depressions are not infrequent.'

No toxic side-effects

One of the substances which stimulate the division of the keratinocytes is the proteinsAPPá. It is produced during the decomposition of a larger protein, APP. The keratinocytes produce an enzyme which cuts the APP down to size as sAPPá: this is known as the á-secretase. Professor Herzog's research team has now blocked these 'molecular scissors'. 'We knew that certain metalloproteinase inhibitors impede the á-secretase. After adding these substances we observed that the discharge of sAPPá was almost completely arrested in the cells of psoriasis patients. As a result, after adding them the greatly increased division rate of the keratinocytes dropped back to normal values by 50 to 60 per cent,' Christina Siemes, a member of Professor Herzog's team, explains. 'We have been able to confirm this in skin specimens of five psoriasis patients.'

The inhibiting effect of the metalloproteinase inhibitors largely wore off within 72 hours. Moreover, even with fivefold concentration of the active ingredient the research team could not detect any toxic side-effects. For example, among other aspects the number of skin cells which entered into apoptosis remained constant - apoptosis is the cells' 'suicide' programme, which enables them to self-destruct when they are malfunctioning. The cellular protein synthesis was also unaffected.

'Treatment using the metalloproteinase inhibitors which we have been investigating seems to be a new and very promising therapeutic option for psoriasis,' Professor Herzog therefore believes. 'This won't be a magic solution to all our problems, of course - after all, every skin reacts differently.' Furthermore, the substances only alleviate the symptoms. They do not remove the root of the evil, viz. the chronic inflammation of the skin caused by constant attacks by the body's own immune system, to which the keratinocytes react with feverish activity in the cell division field.

The researchers now intend to test their method on animals, using naked mice on which they have transplanted the skin tissue of psoriasis patients. They want to apply the active ingredients locally as an ointment. In addition, the first tests on human beings are planned for the immediate future.


Story Source:

The above story is based on materials provided by University Of Bonn. Note: Materials may be edited for content and length.


Cite This Page:

University Of Bonn. "Possible New Cure For Psoriasis." ScienceDaily. ScienceDaily, 17 August 2004. <www.sciencedaily.com/releases/2004/08/040817081007.htm>.
University Of Bonn. (2004, August 17). Possible New Cure For Psoriasis. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2004/08/040817081007.htm
University Of Bonn. "Possible New Cure For Psoriasis." ScienceDaily. www.sciencedaily.com/releases/2004/08/040817081007.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) — Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) — A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) — A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins